PeptidePedia The community reference

Information for Patent expiry and biosimilars

Page information·measured at build time

Technical and provenance information about Patent expiry and biosimilars. All figures on this page are measured from the emitted page rather than declared.

Basic information

Display titlePatent expiry and biosimilars
Default sort keyPatent expiry and biosimilars
NamespaceArticle (main)
Page kindConcept
Page length (source, bytes)4,553
Rendered word count540
Internal wiki links on the page15
Defined citations4
Top-level sections3
Subsections0
Tables0
Figures0
InfoboxYes — concept
Maintenance bannersNone
Indexing by robotsAllowed

Edit history

Page creatorGMP_Gita
Date of page creation12 December 2024
Latest editorPeakShapePol
Date of latest edit14 July 2026
Total number of edits30
Total number of distinct authors25
Minor edits11
Automated (bot) edits2
Recent number of edits (last 90 days)3
Talk page posts4

Principal authors

EditorEditsShareDeclared focus
ShortageShona310.0%compounding law and drug regulation
Chromatokid310.0%analytical chemistry and chromatography
ArchiveBot26.7%policy, notability and deletion
GMP_Gita13.3%compounding law and drug regulation
CoI_Corin13.3%policy, notability and deletion
MoveRequestMio13.3%policy, notability and deletion
TrialsTabitha13.3%clinical trials and evidence appraisal
BaselineBex13.3%laboratory medicine and biomarkers
BUD_Bertram13.3%dosing, titration and injection practice
API_Aurora13.3%compounding law and drug regulation
BiliaryBea13.3%adverse effects and clinical safety
BiosimilarBoaz13.3%compounding law and drug regulation

Category membership